Urinary pseudouridine excretion in myelomatosis. 1985

S H Sørensen, and D A Brown, and E H Cooper, and K A Kelly, and I C MacLennan

Urinary psi excretion is independent of the main indices of tumour activity in myelomatosis (serum paraprotein, serum beta 2-microglobulin, serum creatinine and urinary light chain production). The mean (+/- s.d.) psi at presentation was 40.7 +/- 22.6 nmol. mumol ucr-1, compared to 25.4 +/- 4.8 nmol. mumol ucr-1 in controls. Urinary psi levels at presentation are significantly related to prognosis, the higher the level the poorer the prognosis. However, when these levels have been stratified according to the corresponding level of serum beta 2m, the level adds little as a prognostic factor.

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009101 Multiple Myeloma A malignancy of mature PLASMA CELLS engaging in monoclonal immunoglobulin production. It is characterized by hyperglobulinemia, excess Bence-Jones proteins (free monoclonal IMMUNOGLOBULIN LIGHT CHAINS) in the urine, skeletal destruction, bone pain, and fractures. Other features include ANEMIA; HYPERCALCEMIA; and RENAL INSUFFICIENCY. Myeloma, Plasma-Cell,Kahler Disease,Myeloma, Multiple,Myeloma-Multiple,Myelomatosis,Plasma Cell Myeloma,Cell Myeloma, Plasma,Cell Myelomas, Plasma,Disease, Kahler,Multiple Myelomas,Myeloma Multiple,Myeloma, Plasma Cell,Myeloma-Multiples,Myelomas, Multiple,Myelomas, Plasma Cell,Myelomas, Plasma-Cell,Myelomatoses,Plasma Cell Myelomas,Plasma-Cell Myeloma,Plasma-Cell Myelomas
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D011560 Pseudouridine A naturally-occurring isomer of URIDINE found in RNA, in which ribosyl is attached to a carbon instead of a nitrogen atom.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D001613 beta 2-Microglobulin An 11-kDa protein associated with the outer membrane of many cells including LYMPHOCYTES. It is the small subunit of MHC CLASS I MOLECULES. Association with beta 2-microglobulin is generally required for the transport of class I heavy chains from the endoplasmic reticulum to the cell surface. Beta 2-microglobulin is present in small amounts in serum, CEREBROSPINAL FLUID, and urine of healthy individuals, and to a much greater degree in the urine and plasma of patients with tubular PROTEINURIA, renal failure, or kidney transplants. Thymotaxin,beta 2 Microglobulin
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor
D014529 Uridine A ribonucleoside in which RIBOSE is linked to URACIL. Allo-Uridine,Allouridine,Allo Uridine

Related Publications

S H Sørensen, and D A Brown, and E H Cooper, and K A Kelly, and I C MacLennan
December 1979, Biochemical medicine,
S H Sørensen, and D A Brown, and E H Cooper, and K A Kelly, and I C MacLennan
January 1964, Nature,
S H Sørensen, and D A Brown, and E H Cooper, and K A Kelly, and I C MacLennan
April 1986, Cancer,
S H Sørensen, and D A Brown, and E H Cooper, and K A Kelly, and I C MacLennan
January 1993, Acta oncologica (Stockholm, Sweden),
S H Sørensen, and D A Brown, and E H Cooper, and K A Kelly, and I C MacLennan
January 1971, The Journal of surgical research,
S H Sørensen, and D A Brown, and E H Cooper, and K A Kelly, and I C MacLennan
January 1971, Journal of surgical oncology,
S H Sørensen, and D A Brown, and E H Cooper, and K A Kelly, and I C MacLennan
February 1982, Biochemical medicine,
S H Sørensen, and D A Brown, and E H Cooper, and K A Kelly, and I C MacLennan
January 1965, Neoplasma,
S H Sørensen, and D A Brown, and E H Cooper, and K A Kelly, and I C MacLennan
February 1969, The Biochemical journal,
S H Sørensen, and D A Brown, and E H Cooper, and K A Kelly, and I C MacLennan
October 1978, Biochemical medicine,
Copied contents to your clipboard!